Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Heart Disease, Ischemic

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Heart Disease, Ischemic in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, A1
Jiao, X1
Gao, E1
Li, Y1
Sharifi-Azad, S1
Grunwald, Z1
Ma, XL1
Sun, JZ1
Laude, K1
Richard, V1
Henry, JP1
Lallemand, F1
Thuillez, C1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Heart Disease, Ischemic

ArticleYear
Tonic beta-adrenergic drive provokes proinflammatory and proapoptotic changes in aging mouse heart.
    Rejuvenation research, 2008, Volume: 11, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aging; Amidines; Animals; Apoptosis; Benzylam

2008
Evidence against a role of inducible nitric oxide synthase in the endothelial protective effects of delayed preconditioning.
    British journal of pharmacology, 2000, Volume: 130, Issue:7

    Topics: Acetylcholine; Amidines; Animals; Benzylamines; Coronary Vessels; Endothelium, Vascular; Enzyme Inhi

2000